Annette Künkele

3.0k total citations
49 papers, 1.2k citations indexed

About

Annette Künkele is a scholar working on Oncology, Neurology and Molecular Biology. According to data from OpenAlex, Annette Künkele has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 16 papers in Neurology and 13 papers in Molecular Biology. Recurrent topics in Annette Künkele's work include CAR-T cell therapy research (28 papers), Neuroblastoma Research and Treatments (15 papers) and Virus-based gene therapy research (10 papers). Annette Künkele is often cited by papers focused on CAR-T cell therapy research (28 papers), Neuroblastoma Research and Treatments (15 papers) and Virus-based gene therapy research (10 papers). Annette Künkele collaborates with scholars based in Germany, United States and Netherlands. Annette Künkele's co-authors include Johannes H. Schulte, Angelika Eggert, Michael C. Jensen, Adam Johnson, Cindy A. Chang, Jan J. Molenaar, Lisa S. Rolczynski, Godelieve A.M. Tytgat, Stefan Nierkens and Judith Wienke and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Annette Künkele

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annette Künkele Germany	21	666	498	323	222	190	49	1.2k
Shigeki Yagyu Japan	20	656 1.0×	713 1.4×	164 0.5×	216 1.0×	178 0.9×	67	1.4k
Francesc Martí United States	19	717 1.1×	535 1.1×	96 0.3×	803 3.6×	118 0.6×	57	1.7k
Sneha Ramakrishna United States	12	656 1.0×	726 1.5×	63 0.2×	276 1.2×	208 1.1×	27	1.3k
Xin Tang China	17	674 1.0×	246 0.5×	58 0.2×	399 1.8×	241 1.3×	35	1.1k
Nino Rainusso United States	14	383 0.6×	355 0.7×	66 0.2×	153 0.7×	124 0.7×	37	848
Enkhtsetseg Purev United States	21	755 1.1×	768 1.5×	52 0.2×	308 1.4×	101 0.5×	55	1.6k
Cédric Dos Santos United States	16	571 0.9×	762 1.5×	64 0.2×	396 1.8×	60 0.3×	36	1.5k
Michiel Kroesen Netherlands	12	464 0.7×	350 0.7×	113 0.3×	559 2.5×	190 1.0×	21	1.2k
Stephanie Mgebroff United States	12	1.4k 2.0×	380 0.8×	66 0.2×	698 3.1×	334 1.8×	24	1.7k

Countries citing papers authored by Annette Künkele

Since Specialization

Citations

This map shows the geographic impact of Annette Künkele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Künkele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Künkele more than expected).

Fields of papers citing papers by Annette Künkele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Künkele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Künkele. The network helps show where Annette Künkele may publish in the future.

Co-authorship network of co-authors of Annette Künkele

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Künkele. A scholar is included among the top collaborators of Annette Künkele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Künkele. Annette Künkele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walter, Annette O., Benedikt Obermayer, David R. Busch, et al.. (2025). Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma. Journal for ImmunoTherapy of Cancer. 13(4). e010709–e010709. 6 indexed citations

Petri, Karl, Elvira D’Ippolito, Annette Künkele, et al.. (2025). Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities. Nature Reviews Clinical Oncology. 22(12). 902–923.

Müller, R, Daria Briukhovetska, Justus Weber, et al.. (2024). The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity. Cancers. 16(14). 2608–2608. 6 indexed citations

Scheiermann, Julia, Annette Künkele, Arend von Stackelberg, et al.. (2023). Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease. Frontiers in Immunology. 14. 1042650–1042650. 1 indexed citations

Molenaar, Jan J., et al.. (2023). Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges. European Journal of Cancer. 194. 113347–113347. 5 indexed citations

Buechner, Jochen, Ignazio Caruana, Annette Künkele, et al.. (2022). Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?. Frontiers in Pediatrics. 9. 784024–784024. 16 indexed citations

Hölting, Tilman L. B., Florencia Cidre‐Aranaz, Bastian Popper, et al.. (2022). Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma. Molecular Cancer. 21(1). 199–199. 7 indexed citations

Johnson, Adam, Jia Wei, James M. Rosser, et al.. (2021). Rationally Designed Transgene-Encoded Cell-Surface Polypeptide Tag for Multiplexed Programming of CAR T-cell Synthetic Outputs. Cancer Immunology Research. 9(9). 1047–1060. 8 indexed citations

Klaus, Anika, Annika Winkler, Kathy Astrahantseff, et al.. (2021). Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers. 13(21). 5489–5489. 9 indexed citations

10.

Textor, Ana, Anika Klaus, Annika Winkler, et al.. (2021). CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus. Cancers. 13(5). 1050–1050. 28 indexed citations

11.

Puebla‐Osorio, Nahum, Robin Michelet, Michael R. Green, et al.. (2021). Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model. Cancers. 13(11). 2782–2782. 30 indexed citations

12.

Joedicke, Jara J., et al.. (2021). Accelerating clinical-scale production of BCMA CAR T cells with defined maturation stages. Molecular Therapy — Methods & Clinical Development. 24. 181–198. 21 indexed citations

13.

Wienke, Judith, Miranda P. Dierselhuis, Godelieve A.M. Tytgat, et al.. (2020). The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. European Journal of Cancer. 144. 123–150. 129 indexed citations

14.

Künkele, Annette, Christopher Brown, Stephanie Mgebroff, et al.. (2018). Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion. Biology of Blood and Marrow Transplantation. 25(2). 223–232. 23 indexed citations

15.

Künkele, Annette, Agne Taraseviciute, Laura S. Finn, et al.. (2016). Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility. Clinical Cancer Research. 23(2). 466–477. 75 indexed citations

16.

Künkele, Annette, Adam Johnson, Lisa S. Rolczynski, et al.. (2015). Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas–FasL-Dependent AICD. Cancer Immunology Research. 3(4). 368–379. 130 indexed citations

17.

Künkele, Annette, Dietmar Lohmann, Norbert Bornfeld, et al.. (2015). Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. British Journal of Ophthalmology. 99(7). 949–953. 15 indexed citations

18.

Pajtler, Kristian W., Theresa Thor, Annette Künkele, et al.. (2013). The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathologica Communications. 1(1). 19–19. 25 indexed citations

19.

Künkele, Annette, Katleen De Preter, Lukas C. Heukamp, et al.. (2012). Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro-Oncology. 14(7). 859–869. 44 indexed citations

20.

Künkele, Annette, Katleen De Preter, Jo Vandesompele, et al.. (2011). Pharmacological activation of the p53 pathway by nutlin-3 inhibits medulloblastoma cell proliferation in vitro and in vivo. European Journal of Pediatrics. 170(2). 267–268. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact